STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
257.01
-1.40 (-0.54%)
Nov 17, 2025, 4:00 PM EST - Market closed
STERIS Revenue
STERIS had revenue of $1.46B in the quarter ending September 30, 2025, with 9.89% growth. This brings the company's revenue in the last twelve months to $5.70B, up 7.08% year-over-year. In the fiscal year ending March 31, 2025, STERIS had annual revenue of $5.46B with 6.24% growth.
Revenue (ttm)
$5.70B
Revenue Growth
+7.08%
P/S Ratio
4.43
Revenue / Employee
$320,595
Employees
17,787
Market Cap
25.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.46B | 320.81M | 6.24% |
| Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
STE News
- 11 days ago - STERIS plc (STE) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 12 days ago - STERIS Announces Financial Results for Fiscal 2026 Second Quarter - GlobeNewsWire
- 19 days ago - STERIS Announces Dividend of $0.63 per share - GlobeNewsWire
- 27 days ago - STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025 - GlobeNewsWire
- 3 months ago - Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy - Seeking Alpha
- 3 months ago - STERIS plc (STE) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - STERIS Announces Chief Financial Officer Transition - GlobeNewsWire
- 3 months ago - STERIS Announces Financial Results for Fiscal 2026 First Quarter - GlobeNewsWire